PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1685067
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1685067
The Global Intragastric Balloon Market, valued at USD 68.5 million in 2024, is expected to expand at a CAGR of 14.8% from 2025 to 2034. This surge is driven by advancements in technology, increasing awareness of obesity-related health risks, and greater access to medical support and insurance coverage. The growing prevalence of obesity worldwide has led more individuals to seek non-surgical weight-loss solutions, fueling demand for intragastric balloons. These devices, designed to help patients feel fuller and consume less food, offer a minimally invasive alternative to surgical procedures. Their relatively low cost, coupled with continuous improvements in design and usability, has enhanced their effectiveness and appeal among both healthcare providers and patients.
With rising obesity rates, the need for effective weight-loss interventions has never been greater. Traditional weight-loss methods, including diet and exercise, often fail to deliver long-term results, prompting individuals to explore alternative solutions. Intragastric balloons provide an effective bridge between lifestyle modifications and surgical procedures, offering a temporary yet impactful solution for weight management. Additionally, growing endorsements from medical professionals, coupled with positive patient experiences, are propelling market growth. As consumers become more informed about their options, the preference for non-invasive weight-loss treatments continues to rise, positioning the intragastric balloon market for significant expansion. The increasing adoption of these devices in emerging economies, where obesity rates are climbing, further underscores the market's long-term potential. Ongoing research and development efforts aim to enhance balloon durability, improve patient comfort, and extend treatment duration, ensuring sustained growth in the industry.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $68.5 Million |
Forecast Value | $268.4 Million |
CAGR | 14.8% |
The market is segmented by product type, with single, dual, and triple intragastric balloons available. In 2024, the single intragastric balloon segment generated USD 41.2 million. These balloons are preferred due to their ease of deployment, offering a straightforward insertion process that reduces both procedure time and complication risks. Their simplicity makes them the top choice for both patients and healthcare providers, particularly as they offer a cost-effective alternative to dual-balloon systems. With an increasing focus on accessibility, single intragastric balloons continue to dominate the market, providing an affordable yet highly effective weight-loss solution.
Administration methods in the market include endoscopic and pill forms, with the endoscopic method leading in 2024, holding a 74.3% share. This technique involves inserting the balloon into the stomach using an endoscope, eliminating the need for incisions or stitches. As a minimally invasive option, it reduces risks and recovery time, making it an attractive choice for individuals seeking efficient and low-risk weight-loss procedures. The convenience and safety profile of endoscopic balloon placement has significantly contributed to its widespread adoption, with healthcare facilities increasingly recommending it as a primary intervention for patients struggling with obesity.
The intragastric balloon market in the United States was valued at USD 24.9 million in 2024 and is projected to grow at a 14.8% CAGR through 2034. The U.S. Food and Drug Administration (FDA) approval of these devices has been instrumental in boosting consumer confidence, ensuring patients and healthcare providers recognize their safety and effectiveness. FDA clearance has played a crucial role in increasing adoption, with more individuals incorporating these products into their weight-loss strategies. American consumers are increasingly seeking less invasive treatments with shorter recovery periods and fewer complications, further accelerating the market's expansion. As the demand for innovative and non-surgical weight-loss solutions grows, the intragastric balloon market in the United States is expected to witness robust and sustained growth over the coming years.